Persistent impaired glucose tolerance, insulin resistance, and β-cell dysfunction were independent predictors of type 2 diabetes

Journal of Clinical Epidemiology

Volumn 58, Issue 7, 2005, Pages 728-732

  Li, Chia Lin ^a   Tsai, Shih Tzer ^b   Chou, Pesus ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

cell dysfunction; Diabetes, type 2; Glucose tolerance, impaired, persistent; Glucose tolerance, impaired, transient; Insulin resistance; Metabolic risk profiles

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CELL DAMAGE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TAIWAN; WORLD HEALTH ORGANIZATION;

DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; INCIDENCE; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; OBESITY; PANCREATIC DISEASES; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TAIWAN;

EID: 20444389422     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2004.11.023     Document Type: Article

References (34)

1. M.F. Saad, W.C. Knowler, D.J. Pettitt, R.G. Nelson, D.M. Mott, and P.H. Bennett The natural history of impaired glucose tolerance in the Pima Indians N Engl J Med 319 1988 1500 1506
2. H. King, P. Zimmet, L.R. Raper, and B. Balkau The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study Diabetologia 26 1984 39 43
3. A.G. Schranz Abnormal glucose tolerance in Maltese: a population-based longitudinal study of the natural history of NIDDM and IGT in Malta Diabetes Res Clin Pract 7 1989 7 16
4. G. Nijpels, C. Popp-Snijders, P.J. Kostense, L.M. Bouter, and R.J. Heine Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study Diabetologia 39 1996 113 118
5. A.A. Motala, M.A.K. Omar, and E. Gouws High risk of progression to NIDDM in South African Indians with impaired glucose tolerance Diabetes 42 1993 556 563
6. B.L. Rodriguez, J.D. Curb, C.M. Burchfiel, B. Huang, D.S. Sharp, G.Y. Lu, W. Fujimoto, and K. Yano Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program Diabetes Care 19 1996 587 590
7. J.H. Fuller, M.J. Shipley, G. Rose, R.J. Jarrett, and H. Keen Coronary heart disease and impaired glucose tolerance. The Whitehall Study Lancet 1 1980 1373 1376
8. R.J. Jarrett, P. McCartney, and H. Keen The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics Diabetologia 22 1982 79 84
9. M.F. Saad, W.C. Knowler, D.J. Pettitt, R.G. Nelson, and P.H. Bennett Transient impaired glucose tolerance in Pima Indians: is it important? BMJ 297 1988 1438 1441
10. A.A. Motala, M.A.K. Omar, and E. Gouws Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM Diabetes Care 20 1997 1101 1107
11. G. Riccardi, O. Vaccaro, A. Rivellese, S. Pignalosa, L. Tutino, and M. Mancini Reproducibility of the new diagnostic criteria for impaired glucose tolerance Am J Epidemiol 121 1985 422 429
12. G.T. Ko, J.C. Chan, J. Woo, E. Lau, V.T. Yeung, C.C. Chow, and C.S. Cockram The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors Ann Clin Biochem 33 1998 62 67
13. J. Kobberling, R. Kattermann, and A. Arnold Follow-up of non-diabetic relatives of diabetics by retesting oral glucose tolerance after 5years Diabetologia 11 1975 451 456
14. R.D. Forrest, C.A. Jackson, and J.S. Yudkin The abbreviated glucose tolerance test in screening for diabetes: the Islington Diabetes Survey Diabet Med 5 1988 557 561
15. D.M. Bourn, S.M. Williams, and J.I. Mann Distinguishing between persistent and transient impaired glucose tolerance using a prediction model Diabet Med 9 1992 744 748
16. Q. Qiao, S. Keinanen-Kiukaanniemi, U. Rajala, A. Uusimaki, and S.L. Kivela Risk for diabetes and persistent impaired glucose tolerance among middle-aged Finns Diabetes Res Clin Pract 33 1996 191 198 [Erratum in: Diabetes Res Clin Pract 1997;34:185]
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. P. Chou, C.L. Li, G.S. Wu, and S.T. Tsai Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen: exploring the natural history of type 2 diabetes Diabetes Care 21 1998 1183 1187
19. C.L. Li, S.T. Tsai, and P. Chou Comparison of the results between two diagnostic criteria by ADA and WHO among subjects with FPG 5.6-7.8 mmol/l in Kin-Hu and Kin-Chen, Kinmen, 1991-94 Diabetes Res Clin Pract 45 1999 51 59
20. S.T. Tsai, C.L. Li, C.H. Chen, and P. Chou Community-based epidemiological study of glucose tolerance in Kin-Chen, Kinmen: support for a new intermediate classification J Clin Epidemiol 53 2000 505 510
21. C.L. Li, S.T. Tsai, and P. Chou Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment: the Kinmen Study J Clin Epidemiol 55 2002 19 24
22. C.L. Li, S.T. Tsai, and P. Chou Relative role of insulin resistance and β-cell dysfunction in the progression to type 2 diabetes: the Kinmen Study Diabetes Res Clin Pract 59 2003 225 232
23. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus 1999 World Health Organization Geneva
24. N.W. Kuo, N.P. Yang, W.S. Chang, and P. Chou Community health service: the experience of the Yang-Ming Crusade, 1978-1993 [In Chinese] J Natl Public Health Assoc (ROC) 12 1993 312 321
25. World Health Organization The Asia-Pacific perspective: redefining obesity and its treatment 2000 World Health Organization Geneva
26. D.K. Nagi, W.C. Knowler, M.A. Charles, Q.Z. Liu, R.L. Hanson, D.R. McCance, D.J. Pettitt, and P.H. Bennett Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance Diabetologia 38 1995 187 192
27. M.P. Stern Type II diabetes mellitus: interface between clinical and epidemiological investigation Diabetes Care 11 1988 119 126
28. R.A. DeFronzo Pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview Diabetologia 35 1992 389 397
29. C.N. Hales, and D.J.P. Barker Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis Diabetologia 35 1992 595 601
30. R.C. Temple, C.A. Carrington, S.D. Luzio, D.R. Owens, A.E. Schneider, W.J. Sobey, and C.N. Hales Insulin deficiency in non-insulin-dependent diabetes Lancet 1 8633 1989 293 295
31. S.M. Haffner, H. Miettinen, S.P. Gaskill, and M.P. Stern Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans Diabetes 44 1995 1386 1391
32. S.M. Haffner, R. D'Agostino, and M.F. Saad Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study Diabetes 45 1996 742 748
33. DECODE Study Group Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe Diabetologia 42 1999 647 654
34. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp techniques: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223